Delivery Order SPE2DB22D2206-SPE2DB24FHT37
Award Date 6/13/24
Potential Completion Date 6/14/24
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,131.20, is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 8, 2025. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,429.76 and covers the procurement of CATHFLO ACTIVASE 2 MG VIALS, a medical supply item. The contract is a firm fixed-price delivery order with a completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a medical product, with a firm fixed price of $5,429.76 and a completion date of June 27, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,264.07, is for the delivery of the pharmaceutical product CATHFLO ACTIVASE 2 MG VIALS. The contract is a firm fixed-price delivery order with an ultimate completion date of December 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product, with a ceiling value of $2,076.90 and a completion date of March 19, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,565,778,830 units of the pharmaceutical product CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $9,654.84 and a period of performance through September 13, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to provide critical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,954,863 units of the pharmaceutical product CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $5,140.33 and a performance period through March 14, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,705.55, is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product. The contract type is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 8, 2024. This contract award is not designated as a set-aside....
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,676,853 units of the pharmaceutical product CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $5,025.12 and an ultimate completion date of November 2, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract was not set aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract is for the delivery of 4565282762 units of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a ceiling value of $1,177.99. The contract has a period of performance through July 30, 2024 and does not have a set-aside designation. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...